In B cells, the importance of formation of a macromolecular signaling complex has been suggested in activation of the I B kinase (IKK) -NF-B pathway ( 1, 2 ) . Upon BCR engagement, protein kinase C (PKC) ␤ is activated, which in turn is important for IKK activation ( 3, 4 ) . In addition to PKC ␤ , BCR stimulation requires the adaptor molecules caspase recruitment domain (CARD) 11, Bimp3 (CARMA1), Bcl10, and mucosal-associated lymphoid tissue 1 (MALT1) to activate the IKK complex, consisting of two catalytic subunits (IKK ␣ and IKK ␤ ) and a regulatory subunit (IKK ␥ /NF-B essential modulator) ( 1, 5 ) . Physical interactions between CARMA1 -Bcl10, Bcl10 -MALT1, and CARMA1 -MALT1 proteins have suggested that inducible complex formation is required for signal propagation ( 5, 6 ) . Indeed, overexpression of CARMA1 enhances PMA-and Bcl10-dependent NF-B activation that is blocked by expression of CARMA1 lacking the Bcl10-interacting domain, demonstrating that CARMA1 acts upstream of Bcl10 ( 7, 8 ) . Collectively, these observations indicate that CARMA1 acts as a molecular scaffold to organize the complex formation, including Bcl10 and MALT1 for IKK activation.
Until recently, the molecular mechanism underlying the requirement for PKC ␤ in IKK activation has remained unclear, but data emerging from us and others demonstrate that PKC ␤ -dependent phosphorylation of CARMA1 favorably associates with IKK activation ( 6, 9 -11 ) . In addition, one of these studies shows that mouse Ser564, Ser649, and Ser657 residues in the central linker domain of CARMA1 are potential in vitro PKC ␤ -mediated phosphorylation sites ( 9 ) . However, direct evidence is still lacking about whether these potential sites are indeed phosphorylated in in vivo contexts, and whether these sites are critical for BCR-mediated IKK activation. Moreover, considering the importance of phosphoinositide 3-kinase (PI3K) -dependent kinase 1 (PDK1) in TCR-mediated NF-B activation ( 12 ) , PKC ␤ -mediated phosphorylation of CARMA1 may not be the sole mechanism to explain the action modes of CARMA1 in BCR signaling. . However, it remains unclear whether this PKC ␤ -mediated phosphorylation accounts fully for the activation status of CARMA1, because involvement of other kinases, such as phosphoinositide 3-kinase -dependent kinase 1, has also been suggested. We show that PKC ␤ mediates phosphorylation of CARMA1 on Ser668, which in turn is essential for BCR-mediated CARMA1 -Bcl10 -mucosal-associated lymphoid tissue 1 (MALT1) association and subsequent IKK activation. Our analyses also demonstrate that the downstream kinase IKK ␤ contributes to facilitating formation of the complex CARMA1 -Bcl10 -MALT1 by mediating phosphorylation of CARMA1. Hence, our data suggest that PKC ␤ is crucial for initial activation of IKK. The activated IKK ␤ does not merely function as an effector enzyme but also modifi es the upstream signaling complex through a feedback mechanism, thereby optimizing the strength and duration of the nuclear factor B signal. In this paper, we show that PKC ␤ mediates phosphorylation of CARMA1 on Ser668, which in turn is essential for the CARMA1 -Bcl10 -MALT1 association and subsequent IKK activation. We also provide evidence that the activated IKK ␤ functions as a positive modifi er for the upstream signaling complex, at least partly by mediating phosphorylation of CARMA1.
RESULTS

Importance of multiple Ser/Thr residues in BCR-mediated IKK activation
Given the previous evidence that BCR-mediated CARMA1 phsophorylation is decreased in PKC ␤ -defi cient chicken DT40 B cells ( 6 ), we searched the chicken CARMA1 sequence with the protein database motif engine NetPhos 2.0 (available at http://www.cbs.dtu.dk/services/NetPhos/) to identify its putative phosphorylation sites mediated by PKC ␤ . Nine potential residues Ϫ chicken Thr119, Ser575, Ser578, Ser631, Ser660, Ser668, Ser715, Ser909, and Ser912 Ϫ gave a signifi cant score ( Fig. 1, A and E ) . To test whether these potential phosphorylation modifi cations alter CARMA1 function, each site was mutated, and the resulting mutants harboring C-terminal Flag tag were expressed in CARMA1-defi cient DT40 B cells. For each mutant, multiple clones were tested for functional analysis. Representative clones are presented in Fig. 1 C . Expression levels of S575A and S660A mutants were lower than other CARMA1 mutants; clones expressing high amounts of these mutant CARMA1 could not be obtained, despite our tremendous eff orts. Expression of BCR was comparable in DT40 B cell lines expressing these mutant CARMA1 proteins (unpublished data). Then, we examined the eff ects of these mutations on BCR-mediated IKK activation ( Fig. 1 C ) . Based on the criteria of to what extent BCR-mediated IKK activation is restored, we classifi ed these mutants into three types: (a) similar to wild-type CARMA1, mutants of S660A, S715A, and S912A completely restored IKK activation; (b) restoration was observed, but to a lesser extent compared with wild-type CARMA1 (in the case of S575A and S631A mutants); and (c) mutants of T119A, S578A, S668A, and S909A failed in restoration or barely restored IKK activation after BCR stimulation. Before BCR stimulation, the IKK activation status of the T119A and S909A mutants was reproducibly increased, whereas that of the S578A and S668A mutants was decreased.
Because CARMA1 is also required for BCR-mediated c-Jun N-terminal kinase (JNK) activation ( Fig. 1 B ) in the second and third classes of mutants, we further examined their eff ects on JNK activation. Overall, these mutants gave rise to defects in JNK activation similar to those in IKK activation, except that the S631A mutant manifested the same level of JNK activation as wild-type CARMA1 ( Fig. 1 D ) . Collectively, these data indicate that Thr119, Ser578, Ser668, and Ser909 of CARMA1 play a critical role in IKK as well as JNK activation upon BCR engagement. Therefore, we focused our study on the regulation of CARMA1 function through Thr119, Ser578, Ser668, and Ser909.
Thr119, Ser578, and Ser668 on CARMA1 are phosphorylated upon BCR engagement To examine whether Thr119, Ser578, Ser668, and Ser909 residues on CARMA1 are indeed phosphorylated in BCR signaling, we generated antibodies specifi c for the phosphorylated peptides centered on Thr119, Ser578, Ser668, and Ser909 (anti-pT119, -pS578, -pS668, and -pS909). The specifi city of three antibodies is demonstrated in Fig. 2 A by the lack of detection of the T119A, S578A, and S668A mutants after BCR stimulation. These three sites were also phosphorylated in endogenous CARMA1 upon BCR stimulation (see Fig. 4 C ) . Thus, we conclude that Thr119, Ser578, and Ser668 undergo phosphorylation upon BCR engagement. However, in the case of Ser909, although anti-pS909 antibody recognized the phosphopeptide more effi ciently than the nonphosphopeptide, we could not detect signifi cant diff erences in the band intensity between wild-type CARMA1 and its S909A mutant (unpublished data). Hence, it is more likely that Ser909 contributes to CARMA1 function by its structural role rather than phosphorylation, although we cannot completely exclude the possibility that the level of Ser909 phosphorylation is low, thereby hindering our detection system. Deletion of PKC ␤ almost completely abolished phosphorylation of Ser668. The phosphorylation status of Thr119 and Ser578 was decreased in the absence of PKC ␤ but still occurred ( Fig. 2 B ) . Because Ser668 was phosphorylated in vitro by the addition of active PKC ␤ ( Fig. 2 C ) , we conclude that PKC ␤ is able to phosphorylate Ser668 on CARMA1. In contrast to wild-type CARMA1, the S668A CARMA1 mutant failed to make an inducible association with Bcl10 and MALT1 ( Fig. 2 D ) . Given our previous evidence that wild-type CARMA1 cannot make such inducible association with Bcl10 -MALT1 in the absence of PKC ␤ ( 6 ), these above results demonstrate that PKC ␤ mediates phosphorylation of CARMA1 on Ser668, which in turn is essential for its association with Bcl10 -MALT1 and subsequent IKK activation.
Thus, a question arises as to what is a responsible kinase for phosphorylating Thr119 and Ser578, presumably in cooperation with PKC ␤ . Because the previous report showed that PDK1 participates in IKK activation in the context of TCR T cell activation ( 13 ) . This prompted us to consider the idea that IKK ␤ could participate in the phosphorylation of Thr119 and Ser578. To address this point, we generated IKK ␤ -deficient DT40 B cells. As expected, BCR-mediated IKK activation was abolished in the mutant cells ( Fig. 4, A and B ) . The phosphorylation status of Ser578 was inhibited in IKK ␤ -defi cient DT40 B cells, although its phosphorylation at 3 and 10 min took place to some extent ( Fig. 4 C ) . To further determine the requirement of its kinase activity, kinase-inactive IKK ␤ ( 1 ) was introduced by using a knock-in method (one allele containing knockout and the second allele containing kinase-inactive IKK ␤ ; Fig. 4 D ) . As shown in Fig. 4 E , these mutant cells failed to restore phosphorylation of Ser578. Because Ser578 was phosphorylated in vitro by the addition of recombinant, purifi ed IKK ␤ ( Fig. 4 F ) , we conclude that IKK ␤ is able to phosphorylate Ser578. Collectively, these data suggest that IKK ␤ contributes to mediating phosphorylation of CARMA1 on Ser578. In the case of Thr119 and Ser668, the loss of IKK ␤ suppressed phosphorylation of these sites at early time points ( Fig. 4 C ) , and this decreased phosphorylation of Thr119 and Ser668 appeared to be, at least in part, restored in DT40 cells expressing the kinase-inactive IKK ␤ ( Fig. 4 E ) .
signaling ( 12 ) , one candidate could be PDK1. To address this possibility, we tried to establish PDK1-defi cient DT40 B cells. A conventional knockout method did not allow us to obtain PDK1-defi cient DT40 B cells, simply suggesting that PDK1 is essential for DT40 B cell survival and/or proliferation. Hence, we used a tamoxifen-induced Cre recombination system to establish PDK1-defcient DT40 B cells in a conditional way ( Fig. 3 A ) . Treatment of tamoxifen for 44 h almost abolished expression of PDK1; however, ‫ف‬ 7% of PDK1 protein, determined by densitometric scanning, was still remaining in these conditions ( Fig. 3 B , bottom) . As shown in Fig. 3 B , despite almost complete inhibition of BCR-mediated Akt activation, NF-B was still activated in DT40 cells conditionally deficient in PDK1 after a 44-h tamoxifen treatment. Therefore, it is unlikely that PDK1 plays a signifi cant positive role in BCRmediated IKK activation, although we cannot completely exclude the possibility that the remaining ‫ف‬ 7% of PDK1 is suffi cient for NF-B activation.
Phosphorylation of Ser578 is mediated by IKK ␤ It has been recently reported that IKK ␤ is required for the initial association of Bcl10 and MALT1 with CARMA1 after as well as in DT40 B cells harboring kinase-inactive IKK ␤ ( Fig. 4 E ) , the initial CARMA1 -Bcl10 -MALT1 association was signifi cantly suppressed. Like the S578A mutant, the T119A mutant also manifested the reduced association with Bcl10 and MALT1 ( Fig. 5 B ) .
DISCUSSION
Previous studies have established the contention that IKK ␤ functions downstream of PKC ␤ , CARMA1, Bcl10, and MALT1 on the route of BCR-mediated IKK -NF-B activation ( 1, 2 ) . In this study, we present evidence that, in response to BCR activation, IKK ␤ is not only required for I B phosphorylation but also modifi es assembly of the upstream CARMA1 -Bcl10 -MALT1 complex. Hence, we propose a model whereby two kinases, PKC ␤ and IKK ␤ , sequentially regulate the CARMA1 -Bcl10 -MALT1 complex. First, PKC ␤ -mediated phosphorylation of CARMA1 at Ser668 induces the primary CARMA1 -Bcl10 -MALT1 complex formation and IKK ␤ activation. Subsequently, IKK ␤ modifi es phosphorylation Because phosphorylation of Thr119 and Ser668 could not be detected by recombinant, purifi ed IKK ␤ in our experimental conditions, it is likely that IKK ␤ contributes to the initial phosphorylation of Thr119 and Ser668 in a kinaseindependent manner.
Loss of IKK ␤ inhibited phosphorylation of Ser578 1 min after BCR stimulation, simply suggesting that IKK ␤ might be activated at 1 min after BCR stimulation, although the level is low. Thus, we examined the time kinetics of IKK activation in more detail. As shown in Fig. 5 A (bottom) , IKK ␤ was indeed activated, albeit to a small extent, 1 min after BCR engagement. Because IKK ␤ activation is primarily dependent on PKC ␤ in BCR signaling, these observations imply the idea that the primed IKK ␤ , in turn, could promote phosphorylation of Ser578 on CARMA1, thereby contributing to maximal IKK activation by enhancing CARMA1 -Bcl10 -MALT1 association. In support of this idea, the S578A CARMA1 mutant exhibited the reduced level of its association with Bcl10 and MALT1 ( Fig. 5 B ) . Moreover, in IKK ␤ -defi cient DT40 B cells ( Fig. 5 C ) Given that the IKK complex is recruited to the CARMA1 -Bcl10 -MALT1 complex after antigen receptor stimulation, two, although not necessarily mutually exclusive, explanations for the eff ects of IKK ␤ on CARMA1 phosphorylation are possible. First, upon recruitment of IKK ␤ to the CARMA1 -Bcl10 -MALT1 complex, IKK ␤ would be activated, thereby directly phosphorylating CARMA1. Alternatively, because other kinases such as PKC ␤ are also thought to be recruited to the CARMA1 -Bcl10 -MALT1 complex, the recruited IKK ␤ to the same complex might regulate these kinases, of CARMA1 on key residues, including Ser578, and enhances the assembly of CARMA1 -Bcl10 -MALT1, resulting in an increased ability of CARMA1 to activate IKK. Although the data presented here reveal the involvement of PKC ␤ and IKK ␤ in the phosphorylation of CARMA1, other kinases also appear to participate in. For instance, phosphorylation of Thr119 still occurred even in the absence of either PKC ␤ or IKK ␤ . Moreover, as our study has focused on putative PKC ␤ -mediated phosphorylation sites on CARMA1, it remains possible that additional phosphorylation sites participate in IKK activation. the mutant DT40 B cells demonstrated normal BCR-mediated NF-B activation. This diff erence might refl ect a distinct requirement for upstream signaling events in PKC ␤ and PKC activation between B and T cells, respectively; BCRmediated phospholipase C ␥ activation might be suffi cient for subsequent PKC ␤ activation, whereas PKC activation might require PI3K-mediated PDK1 activity in T cells, probably in addition to phospholipase C ␥ activation. Supporting this possibility, PDK1 is reported to associate with PKC in CD3/ CD28-stimulated T cells ( 12 ) . Alternatively, as previously proposed ( 12 ), recruitment of CARMA1 and PKC into the plasma membrane, presumably raft fractions, requires PDK1 activity in the case of T cell activation. Then, activated PKC catalyzes phosphorylation of CARMA1. In contrast, both functions might be exerted by PKC ␤ in B cells.
Ser575, Ser578, Ser631, Ser660, and Ser668 in the CARMA1 linker region are predicted to be potential PKC ␤ phosphorylation sites. Among these sites, mutation of Ser578 or Ser668 led to an almost complete defect in BCR-mediated IKK activation, whereas mutation of Ser575 or Ser631 resulted in its partial defect. Although not being formally proven, because of the lack of antibodies toward phospho-Ser575 and phospho-Ser631, the extent of phosphorylation of the S575A or S631A mutant was decreased, as determined by anti -phospho-Ser/-Thr antibody (unpublished data), suggesting that these sites are probably phosphorylated in BCR signaling. In regard to the functional importance of Ser668 (corresponding to Ser657 in mouse and Ser645 in human), two previous papers with Jurkat T cells demonstrated that this site was partially, rather than completely, involved in TCR/CD28-mediated IKK activation ( 9, 10 ) . The reason why BCR-mediated IKK activation had a more stringent requirement for phosphorylation thereby promoting phosphorylation of CARMA1. In this mechanism, the IKK ␤ kinase activity might not be necessarily required. In the case of phosphorylation of Ser578, we favor the former idea because of two lines of evidence: (a) the inhibition of phosphorylation on Ser578 in DT40 B cells harboring kinase-inactive IKK ␤ and (b) the capability of recombinant IKK ␤ to phosphorylate Ser578. However, the contribution of IKK ␤ to the initial phosphorylation of Thr119 and Ser668 in a kinase-independent manner suggests that the latter mechanism would also operate. Together, we would like to propose that IKK ␤ utilizes both mechanisms to promote phosphorylation of the upstream adaptor, CARMA1.
Ser578 does not mach the classical IKK consensus motif (DS ⌿ XXS) found in all I B proteins, ␤ -catenin, and FOXO3a ( 14 -16 ). But, the conservation of this motif seems to refl ect the constraints for recognition of SCF-␤ TRCP E3 ligase and subsequent proteosomal degradation rather than an IKK phosphoacceptor site. The identifi cation of other IKK ␤ substrates will allow a better understanding about the molecular parameters for kinase recognition and IKK ␤ consensus sequences. Although IKK ␤ is one of the kinases responsible for phosphorylation of Ser578, the residual phosphorylation of this site in IKK ␤ -deficient DT40 cells was clearly observed, presumably because of PKC ␤ , because reduction of phosphorylation status at Ser578 was also reproducibly observed in PKC ␤ -defi cient cells.
PDK1-knockdown Jurkat T cells, generated with the use of short hairpin RNA for PDK1, manifested severe defects in CD3/CD28-dependent NF-B activation, although these knockdown cells apparently had remaining PDK1 ( 12 ) . Despite similar levels of remaining PDK1 between knockdown Jurkat cells and DT40 B cells conditionally defi cient in PDK1, and Malt1 ( 13, 22 ) . Collectively, it is reasonable to anticipate that IKK ␤ can induce both positive-and negative-feedback loops by phosphorylating upstream signaling molecules. Moreover, these feedback loops are considered to be required for the optimal activation of NF-B induced by antigen receptor stimulation. Thus, further studies should be aimed at deciphering when and where these loops can operate, thereby changing the strength and duration of NF-B signals.
MATERIALS AND METHODS
Cells, antibodies, and reagents. Wild-type and various mutant DT40 cells were cultured as described previously ( 6 ). 4-hydroxy tamoxifen (4OH-T) was purchased from Sigma-Aldrich. Anti -phospho-CARMA1 antibodies were obtained by immunizing rabbits with synthetic phosphorylated peptides (pT119, CTRRFST(PO 3 )IVV-COOH; pS578, IMS(PO 3 )TTPEPPC-COOH; and pS668, CPFRPS(PO 3 )VTSV-COOH). Anti -chicken IgM mAb, M4 ( 6 ), was used for stimulation of BCR. The following antibodies were purchased: anti -extracellular signal-regulated kinase (ERK), anti-JNK, antiBcl10 mAb (331.3), and anti-Akt (Santa Cruz Biotechnology, Inc.); anti-PKC ␤ II, anti-CARMA1, anti-IKK ␥ pAb, anti-IKK ␤ , and anti-PDK1 (Abcam); anti-IKK ␥ and anti-IKK ␣ mAbs (BD Biosciences); anti -phospho-ERK, antiphospho-I B ␣ mAb (5A5), anti -phospho-JNK, anti -phospho -T308-Akt, and anti -phospho -S473-Akt (Cell Signaling Technology); and anti-FLAG mAb (M2; Sigma-Aldrich). Anti-CARMA1 antibody for immuno precipitation was obtained as described previously ( 6 ) .
Expression constructs and transfection. Flag-tagged chicken wild-type CARMA1 and its mutant complementary DNAs (cDNAs) were generated by PCR. Each cDNA was cloned into the pApuro with IRES-GFP expression vector, as previously described ( 6 ), or into the knock-in vector with IRES-GFP and the puro-resistant gene (pBIG) for introduction into the endogenous ␤ -actin locus. The knock-in construct places the transgenes under the control of the endogenous ␤ -actin promoter and enables the acquisition of clones expressing the same and proper (approximately twofold higher than endogenous CARMA1) protein expression levels. These constructs were transfected into various mutant DT40 cells by electroporation.
Generation of IKK ␤ -and PDK1-defi cient DT40 cells. Genomic clones of IKK ␤ and PDK1 were obtained by PCR using oligonucleotides designed by the National Center for Biotechnology Information chicken genome database sequences (available from GenBank/EMBL/DDBJ under accession nos. LOC426792 and LOC416588 , respectively) as a primer and DT40 genomic DNA as a template. The targeting constructs for IKK ␤ were designed for neo and hisD cassettes to replace exons 1 -14 of the chicken IKK ␤ gene. The targeting vector, pPDK1-hisD, was constructed by replacing the genomic fragment containing exons 3 -6 that correspond to the mouse PDK1 ATP-binding domain with hisD cassette. The fi rst allele was disrupted by the pPDK1-hisD, and the second allele was replaced by the conditional construct, which was designed as shown in Fig. 3 A . Like the second alleletargeting vector for PDK1, IKK ␤ knock-in vectors (wild type and its S176/ 181A [SSAA] mutant) were constructed to make a miniature gene in the endogenous IKK ␤ locus. The fi rst allele of IKK ␤ was disrupted by the pIKK ␤ -hisD, and the second allele was replaced by the knock-in targeting constructs. BCR expression on DT40 B cells defi cient in IKK ␤ and PDK1 was essentially the same as wild-type cells.
Immunoprecipitation and Western blot analysis. Western blot analysis and immunoprecipitation were performed as described previously ( 6 ) .
Kinase assay. IKK kinase assay was performed as described previously ( 6 ) . For in vitro kinase assay of PKC ␤ , PDK1, IKK ␣ , and IKK ␤ , recombinant active kinases were purchased from Millipore. CARMA1 as a substrate was purifi ed from PKC ␤ -defi cient DT40 cells expressing wild-type Flag-tagged CARMA1 ( 6 ). After being lysed by 1% NP-40 lysis buff er without phosphatase of Ser668 in DT40 B cells could be explained by the following three possibilities. First, this diff erence might simply refl ect a species diff erence between chicken and mouse/human. Second, as discussed in the requirement for PDK1 between B and T cells, this diff erence might refl ect a diff erential requirement for upstream kinases (PKC ␤ vs. PKC ) in B and T cells, respectively. Ser668 could be used more dominantly as an in vivo phosphorylation site by PKC ␤ in B cells, rather than PKC in T cells. Finally, because we used the antigen receptor as a stimulant, in contrast to co-stimulation with antigen receptors and coreceptors (CD3/CD28) in the case of Jurkat T cells, phosphorylation of Ser668 might be used more stringently in the antigen receptor signaling context. As CD28 is known to enhance antigen receptor signaling, presumably through PI3K activation ( 17 ) , such augmented PI3K might lower the threshold for the requirement of Ser668 in IKK activation.
The available evidence indicates that Bcl10 is recruited to the CARD of CARMA1 and that MALT1 is recruited to Bcl10 through the binding of the MALT1 immunoglobulin domains to the region of Bcl10 located just C-terminal of the CARD (for review see reference 5 ). Indeed, deletion of the CARD of CARMA1 blocked its association with Bcl10 and MALT1. More importantly, deletion or mutation of the CARD of CARMA1 abrogated CARMA1 function to activate NF-B after TCR stimulation ( 7, 18 -20 ) . In the case of DT40 B cells, we also observed that the CARD deletion of CARMA1 almost failed to associate with Bcl10 -MALT1 as well as to activate BCR-mediated IKK activation (unpublished data). Thus, the decreased association of the T119A, S578A, or S668A CARMA1 mutant with Bcl10 -MALT1 is likely to be one of the major causes for why these mutants could not activate IKK. It has been proposed that the linker domain of CARMA1 in the unstimulated stage might bind to its own CARD through an intramolecular interaction ( 21 ) . Once Ser668 is phosphorylated, this interaction could be disrupted, thereby initiating exposure of the CARMA1 CARD to Bcl10. In addition, given the importance of forming homooligomerization of CARMA1 in NF-B activation, phosphorylation of Ser668 may induce or stabilize CARMA1 oligomerization, which in turn contributes to CARMA1 -Bcl10 -MALT1 association ( 6, 21 ) . Phosphorylation of Ser578 probably utilizes a similar mechanism to that of Ser668 to induce a conformational change of CARMA1. The location of Ser119 (between the N-terminal CARD-coiled-coil domains; Fig. 1 A ) might provide an insight into the action mechanism of its phosphorylation. Assuming that the coiled-coil domain binds to the CARD in the unstimulated state, this interaction could be disrupted by phosphorylation of Ser119, thereby contributing to exposing the CARD to Bcl10 as well as to forming homooligomerization of CARMA1.
Although we have revealed an as yet unappreciated role of IKK ␤ in amplifying the NF-B signal by regulating the upstream complex, our study does not invalidate the role of IKK ␤ in dampening the NF-B signal, as proposed in T cells. Recent papers have shown that IKK ␤ phosphorylates Bcl10, thereby inducing its degradation and disengagement of Bcl10 inhibitor, Flag-tagged CARMA1 was immunoprecipitated by M2-beads (Sigma-Aldrich) and eluted by 100 g/ml of Flag peptide (NDYKDDDD-KDYKDDDDKDYKDDDDKN). In vitro kinase assay was performed according to the manufacturer ' s instructions (Millipore).
